UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Terminated
Unique ID issued by UMIN UMIN000033836
Receipt No. R000038592
Scientific Title Effect of daily intake of the test food on serum lipid levels and body composition
Date of disclosure of the study information 2019/04/01
Last modified on 2018/09/05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of daily intake of the test food on serum lipid levels and body composition
Acronym Effect of the test food intake on serum lipid levels and body composition
Scientific Title Effect of daily intake of the test food on serum lipid levels and body composition
Scientific Title:Acronym Effect of the test food intake on serum lipid levels and body composition
Region
Japan

Condition
Condition Body mass index (BMI): above 25 and less than 30 adult men and women
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To estimate the effect of the test food on serum lipid levels and body composition
Basic objectives2 Others
Basic objectives -Others Timing: Pre-health check/after 8w feeding
Inquiry (Inquiry, Blood pressure, pulsation, Weight, Fat %)
Analysis of urine (Urinary protein, sugar, urobilinogen, ALB, AST(GOT), ALT(GPT), LDH, T-Bil, ALP, gamma-GTP, CPK, Ca, Fe, Mg, T-cho, LDL-C, HDL-C, TG, GLC(GLU), HbA1c(NGSP)
General blood check (leucocyte, erythrocyte, hemoglobin, Hematocrit, blood platelet)
Thyroid function tests : FT3, FT4, TSH
# of blood sampling: 1 blood sample/ period
Timing of blood sampling:
0W/ 8W
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes Visceral fat area
Key secondary outcomes Serum lipids (total cholesterol, LDL-cholesterol, Triglyceride), Body weight, Body mass index (BMI), Body composition

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification YES
Dynamic allocation YES
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Non powdered kelp contains maltitol and crystalline cellulose.
Ten tablets x 3times / day during meal
Feeding period; 8 weeks
Interventions/Control_2 Powdered kelp: One tablet contains 196.7mg of powdered kelp.
Powdered kelp 0.11g / tablet as dietary fiber.
Key alginate contains 101mg / tablet, Iodine contains 0.0387mg / tablet (1.16mg / day; less than 3mg / day of tolerable upper intake level).
Ten tablets x 3times / day during meal
Feeding period: 8 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Basically healthy person
Body mass index (BMI) is above 25 and less than 30.
Key exclusion criteria (1) The person with severe disease in the liver, kidney, heart, lung, digestive organs, blood, endocrine, and urology.
(2) The person who is undergoing therapeutic treatment or take a drug at the time of informed consent agreement.
(3) Person having food or drug allergy, hypersensitivity, or those medical history.
(4) Person who cannot eat kelp
(5) Person who eats FOSHU, Foods with Function Claims, Supplement, So-called health food rich in dietary fiber daily.
(6) Person who is controlled or limited iodine intake.
(7) Person who drinks excessive alcohol (above 30g/day as alcohol).
(8) Person with abnormal food habit or irregular life style such as shifts workers or late-night workers.
(9) Person participating in an examination to apply an intake of other food and the examination using the drug, person with the intention of the participation within 4 weeks or after informed consent agreement of present test.
(10) Men who carried out the whole blood donation of 400ml from start of this test three months ago.
(11) Women who carried out the whole blood donation of 400ml from start of this test four months ago.
(12) Person who judged an examination responsibility doctor to be inappropriate as a subject
Target sample size 30

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Seiichiro Aoe
Organization Otsuma Women's University
Division name Faculty of Home Economics Department Food Science
Zip code
Address 12 Sanban-cho,Chiyoda-ku,Tokyo
TEL +81-3-5275-6048
Email s-aoe@otsuma.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Seiichiro Aoe
Organization Otsuma Women's University
Division name Faculty of Home Economics Department Food Science
Zip code
Address 12 Sanban-cho, Chiyoda-ku, Tokyo 102-8357, Japan
TEL +81-3-5275-6048
Homepage URL
Email s-aoe@otsuma.ac.jp

Sponsor
Institute Seiichiro Aoe
Otsuma Women's University
Faculty of Home Economics
Department Food Science
Institute
Department

Funding Source
Organization Hokkaido Federation of Fisheries Associations
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor Maruyanagi Foods Inc.
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大妻女子大学(東京都)/Otsuma Women’s university (Tokyo)
CPCC株式会社/CPCC Company Limited

Other administrative information
Date of disclosure of the study information
2019 Year 04 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2018 Year 08 Month 17 Day
Date of IRB
Anticipated trial start date
2018 Year 08 Month 23 Day
Last follow-up date
Date of closure to data entry
2018 Year 09 Month 06 Day
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2018 Year 08 Month 21 Day
Last modified on
2018 Year 09 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038592

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.